Revlimid (Celgene Corporation)
Welcome to the PulseAid listing for the Revlimid drug offered from Celgene Corporation. This Thalidomide Analog [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Celgene Corporation |
| NON-PROPRIETARY NAME: | Lenalidomide |
| SUBSTANCE NAME: | LENALIDOMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Thalidomide Analog [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-04-16 |
| END MARKETING DATE: | 0000-00-00 |
Revlimid HUMAN PRESCRIPTION DRUG Details:
| Item Description | Revlimid from Celgene Corporation |
| LABELER NAME: | Celgene Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.5(mg/1) |
| START MARKETING DATE: | 2012-04-16 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 59572-402_95a0b71b-69ee-4067-9580-4f89fcdd377b |
| PRODUCT NDC: | 59572-402 |
| APPLICATION NUMBER: | NDA021880 |
Other LENALIDOMIDE Pharmaceutical Manufacturers / Labelers:
